Stoffwechsel & Herzrisiko Check-Up

An eleven-biomarker panel combining comprehensive lipid analysis with metabolic and thyroid markers to assess cardiovascular risk and metabolic health. Includes advanced lipid markers such as apolipoproteins A1 and B, lipoprotein(a), and non-HDL cholesterol alongside HbA1c, HOMA index, and TSH. Fasting is required.

Standard lipid panels measure total cholesterol, HDL, LDL, and triglycerides — but these four markers tell only part of the cardiovascular risk story. This panel goes further by adding apolipoprotein A1 (the primary protein in HDL particles), apolipoprotein B (a marker of atherogenic particle number), and lipoprotein(a) — a genetically determined risk factor that is independent of LDL levels and is increasingly recognised as a significant predictor of cardiovascular events. Non-HDL cholesterol provides a single number capturing all atherogenic lipoproteins, which some guidelines consider more predictive than LDL alone. The metabolic component adds HbA1c (a three-month average of blood sugar control) and the HOMA index (a calculated measure of insulin resistance), offering early detection of metabolic dysregulation before fasting glucose alone would flag a problem. TSH screens for thyroid dysfunction, which can significantly influence both lipid levels and metabolic rate. Fasting for this panel is required to ensure accurate triglyceride and glucose-dependent calculations. The combination of advanced lipid markers with insulin resistance screening makes this panel particularly valuable for individuals with a family history of heart disease, those with borderline conventional lipid results, or anyone seeking a more granular understanding of their cardiovascular and metabolic risk profile than a standard cholesterol check provides.